Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.


We like to move it – patients with schizophrenia spectrum disorders are impaired in estimating their physical fitness levels and benefit from individualized exercise
Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis
Which Are the Optimal Screening Tools for Internet Use Disorder in Children and Adolescents? A Systematic Review of Psychometric Evidence
Neurobiologie und Wirkmodelle zu Psychedelika
Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis
Anhedonia as a potential transdiagnostic phenotype with immune-related changes in recent onset mental health disorders


We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.


About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.



Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top